CHYM vs BMNR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CHYM Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Chime Financial, Inc. Class A Common Stock (CHYM) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BMNR counters with relative strength in Valuation. Fundamentally, CHYM trades at 31.6x Forward P/E with 19.3% operating margin (+32.1% YoY revenue) versus BMNR at 7.0x Forward P/E and -216.3% operating margin (+4801.3% YoY). In options structure, CHYM sits in CONSOLIDATION (12th %ile IV; Dealer Gamma Walls on Pro) against BMNR sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CHYM Revenue | BMNR Revenue | CHYM Op. Margin | BMNR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | N/A | $0M | N/A | -400.8% | BMNR |
| FY2023 | $1.28B | $0M | -18.4% | -374.0% | CHYM |
| FY2024 | $1.67B | $0M | -3.7% | -74.0% | CHYM |
| FY2025 | $2.19B | $10M | -47.6% | 7288.1% | BMNR |
| FY2026 | N/A | $120M | N/A | -5207.4% | BMNR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CHYM | BMNR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.9B | $11.0B | Larger Scale | CHYM |
| Trailing P/E Ratio Valuation | 29.4x | N/M | Lower Multiple | CHYM |
| Forward P/E Ratio Valuation | 31.6x | 7.0x | Lower Multiple | BMNR |
| Revenue Growth (YoY) Growth | +32.1% | +4801.3% | Higher Growth | BMNR |
| Operating Margin (TTM) Profitability | 19.3% | -216.3% | Higher Margin | CHYM |
| Net Profit Margin Profitability | 3.0% | 0.0% | Higher Margin | CHYM |
| Return on Equity (ROE) Capital Efficiency | 5.4% | -52.4% | Higher ROE | CHYM |
| 52-Week Range Position Momentum | 92% ($16โ$36) | 13% ($13โ$40) | Stronger Trend | CHYM |
| Beta / 30D Volatility Risk Regime | 1.45ฮฒ ยท 36% Vol | 3.12ฮฒ ยท 83% Vol | Lower Realized Risk | CHYM |
| Unified Institutional Score Composite Signal | 33.1 / 100 (SELL) | 47.7 / 100 (HOLD) | Higher Composite | BMNR |